Clinical Trial Update: PIPAC With Nab-paclitaxel and Cisplatin in Peritoneal Carcinomatosis [Phase 1]

View source ↗

Summary

Clinical trial update for a Phase 1 study of PIPAC using nab-paclitaxel and cisplatin in peritoneal carcinomatosis; the study is currently active but not recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peritoneal Carcinomatosis

Drugs mentioned

• Abraxane (nab-paclitaxel) (nab-paclitaxel)
• CISPLATIN (cisplatin)

Snippet

Sponsor: University Hospital, Geneva | Conditions: Peritoneal Carcinomatosis | Phase 1 | Status: ACTIVE_NOT_RECRUITING